Type
Bankruptcy
Country
France
Region
île de France; Yvelines;
Location of affected unit(s)
Vélizy-Villacoublay
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations

130 jobs
Number of planned job losses
Job loss
Announcement Date
9 April 2011
Employment effect (start)
1 May 2011
Foreseen end date

Description

DMH-Negma, a subsidiary of the pharmaceutical Indian group Wockhardt, announced its intention to lay off its 130 sales representatives. The company had been placed into compulsory liquidation on 25 March 2011.

DMH-Negma is a fully integrated pharmaceutical Group mastering the various stages of the life cycle of its products from R&D, API manufacturing, to manufacturing, conditioning and packaging of final products, and finally the promotion to prescribers and distribution to wholesalers and pharmacies.

Wockhardt is a pharmaceutical and biotechnology company headquartered in Mumbai, India. The company has manufacturing plants in India, UK, Ireland, France and US, and subsidiaries in US, UK, Ireland and France. It produces formulations, biopharmaceuticals, nutrition products, vaccines and active pharmaceutical ingredients. The company employs over 7,000 people globally.


Sources

Citation

Eurofound (2011), DMH-Negma, Bankruptcy in France, factsheet number 71877, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/71877.